A sustainable model for antibiotics

Science

Volumn 347, Issue 6226, 2015, Pages 1062-1064

  Perros, Manos ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; MOLECULAR LIBRARY;

ANTIBIOTICS; GENE EXPRESSION; GENETIC ANALYSIS; MATHEMATICAL ANALYSIS; MOLECULAR ANALYSIS; NUMERICAL MODEL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL CELL; BACTERIAL INFECTION; BACTERIUM ISOLATE; BASIC RESEARCH; CLINICAL PRACTICE; DRUG INDUSTRY; GRAM NEGATIVE BACTERIUM; HOSPITAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KLEBSIELLA PNEUMONIAE; MOLECULAR DIAGNOSTICS; MOLECULAR LIBRARY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; HUMAN; PERSONALIZED MEDICINE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; DRUG DISCOVERY; DRUG RESISTANCE, BACTERIAL; HUMANS; INDIVIDUALIZED MEDICINE; KLEBSIELLA PNEUMONIAE; SMALL MOLECULE LIBRARIES;

EID: 84924366280     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaa3048     Document Type: Review

References (19)

1. H. W. Boucher et al., Infectious Diseases Society of America, Clin. Infect. Dis. 56, 1685 (2013).
2. D. M. Livermore, Int. J. Antimicrob. Agents 39, 283 (2012).
3. I. Karaiskos, H. Giamarellou, Expert Opin. Pharmacother. 15, 1351 (2014).
4. P. M. Hawkey, A. M. Jones, J. Antimicrob. Chemother. 64 (suppl. 1), i3 (2009).
5. S. Baker, Science 347, 1064 (2015).
6. See www.imi.europa.eu/content/translocation.
7. See https://longitudeprize.org/.
8. See www.nih.gov/about/director/09182014-statement-brain-amr.htm.
9. D. J. Payne et al., Nat. Rev. Drug Discov. 6, 29 (2007).
10. J. M. Pagès, C. E. James, M. Winterhalter, Nat. Rev. Microbiol. 6, 893 (2008).
11. S. Biswas et al., Nat. Struct. Mol. Biol. 14, 1108 (2007).
12. L. L. Ling et al., Nature 517, 455 (2015).
13. N. P. Braykov, M. R. Eber, E. Y. Klein, D. J. Morgan, R. Laxminarayan, Infect. Control Hosp. Epidemiol. 34, 259 (2013).
14. F. C. Tenover et al., J. Clin. Microbiol. 51, 3780 (2013).
15. E. Mylonakis et al., Clin. Infect. Dis. 10.1093/cid/ciu959 (2015).
16. N. R. Pace, Science 276, 734 (1997).
17. A. Y. Peleg, H. Seifert, D. L. Paterson, Clin. Microbiol. Rev. 21, 538 (2008).
18. B. Spellberg, J. H. Rex, Nat. Rev. Drug Discov. 12, 963 (2013).
19. Data reproduced with permission from IMS Health International MIDAS Data 1999-2010.